News

Latest News
Nov 12, 2019

Nov. 12, 2019 The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Mylan’s API manufacturer, Mylan Laboratories Limited Unit 8, on November 5, 2019. The concerns cited by the...

Nov 12, 2019

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be...

Nov 5, 2019

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and nine months ended September 30, 2019. Third Quarter 2019 Financial Highlights U.S. GAAP diluted earnings per...

Oct 25, 2019

Mylan Pharmaceuticals Inc. is conducting a voluntary nationwide recall of one lot (see table below) of Alprazolam Tablets, USP C-IV 0.5 mg, to the consumer/user level. This lot is being recalled...

Oct 24, 2019

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its third quarter 2019 financial results on Tuesday, Nov. 5 before the open of the U.S. financial...

View More

Search News Releases
Contact Mylan Communications

Global Communications 
724.514.1968
communications@mylan.com

Stay Connected

Mylan: Seeing is Believing

You are leaving Mylan.com

By clicking Continue below you are leaving Mylan.com and going to a third-party site.